View Author
dai: 068112564
scopus: 35397577500
Kwast, Th.H. van der
(Theo van der Kwast)Supervisor (promotor) of 15 dissertations
cancer patient prostate tumor prostate cancer study biopsy screening bladder mutation antigen expression recurrence analysis grade stage table tumour group bladder cancer number round carcinoma result volume progression factor response urine tissue detection level van der kwast value spleen diagnosis tumours growth model prognostic fgfr 3 mutations marker treatment gleason lesion disease receptor follow-up sample pathologist european randomized study interval spleen cells european prostatectomy prostatic month cystoscopy androgen urology urothelial score pathology survival rotterdam t cells control erspc memory adenocarcinoma lymphocytes fgfr 3 mutation specimen antibody protein netherland kwast surveillance fgfr 3 pathol
10 Most Recent Publications
|
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy
(Article)
Wolters, T. Montironi, R. Kwast, Th.H. van der Mazzucchelli, R. Scarpelli, M. Roobol, M.J. Bergh, R.C.N. van den Leeuwen, P.J. van Hoedemaeker, R.F. Leenders, G.J. van Schröder, F.H. |
2012-01-01
|
|
The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful?
(Article)
Ghanem, M.A. Kwast, Th.H. van der Molenaar, W.M. Safan, M.A. Nijman, J.M. Steenbrugge, G.J. van |
2011-05-19
|
|
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort
(Article)
Trottier, G. Roobol, M.J. Zlotta, A.R. Fleshner, N.E. Lawrentschuk, N. Boström, P.J. Fernandes, K.A. Finelli, A. Chadwick, K. Evans, A. Kwast, Th.H. van der Toi, A. |
2011-04-22
|
|
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment
(Article)
Kakiashvili, D.M. Rhijn, B.W.G. van Hanna, S. Kostynsky, A. Kuk, C. Kwast, Th.H. van der Zlotta, A.R. Trottier, G. Jewett, M.A.S. Fleshner, N.E. Finelli, A. Azuero, J. Bangma, C.H. Vajpeyi, R. Alkhateeb, S. |
2011-02-01
|
|
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial
(Article)
Wolters, T. Roobol, M.J. Leeuwen, P.J. van Bergh, R.C.N. van den Hoedemaeker, R.F. Leenders, G.J. van Schrder, F.H. Kwast, Th.H. van der |
2011-01-01
|
|
FGFR3, HRAS, KRAS, NRAS AND PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy
(Article)
Kompier, L.C. Lurkin, I. Aa, M.N.M. van der Rhijn, B.W.G. van Kwast, Th.H. van der Zwarthoff, E.C. |
2010-11-18
|
|
Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer
(Article)
Laurila, M. Kwast, Th.H. van der Bubendorf, L. Lollo, S. di Pihl, C.G. Ciatto, S. Hugosson, J. Määttänen, L. Roobol, M.J. Kujala, P.M. |
2010-11-01
|
|
Expression and prognostic value of platelet-derived growth factor-AA and its receptor α in nephroblastoma
(Article)
Ghanem, M. Nijman, R. Safan, M.A. Kwast, Th.H. van der Vansteenbrugge, G. |
2010-11-01
|
|
Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989-2006
(Article)
Cremers, R.G.H.M. Karim-Kos, H.E. Houterman, S. Verhoeven, R.H.A. Schroder, F.H. Kwast, Th.H. van der Kil, P.J.M. Coebergh, J.W.W. Kiemeney, L.A.L.M. |
2010-07-01
|
|
Pathological stage review is indicated in primary pT1 bladder cancer
(Article)
Rhijn, B.W.G. van Kwast, Th.H. van der Kakiashvili, D.M. Fleshner, N.E. Aa, M.N.M. van der Alkhateeb, S. Bangma, C.H. Jewett, M.A.S. Zlotta, A.R. |
2010-07-01
|
